44 Wealth Management’s Idexx Laboratories IDXX Stock Holding History

44 Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,682	Closed	-$874K	–	176
2022 Q3	$874K	Buy	2,682 +16	+0.6%	+$5.88K	0.36%	75
2022 Q2	$935K	Sell	2,666 -44	-2%	-$17.9K	0.36%	75
2022 Q1	$1.48M	Sell	2,710 -233	-8%	-$123K	0.53%	51
2021 Q4	$1.94M	Sell	2,943 -45	-2%	-$28.2K	0.67%	40
2021 Q3	$1.86M	Sell	2,988 -67	-2%	-$45K	0.71%	42
2021 Q2	$1.93M	Buy	+3,055	New	+$1.69M	0.74%	38
2021 Q1	–	Sell	-2,442	Closed	-$1.22M	–	169
2020 Q4	$1.22M	Buy	+2,442	New	+$1.09M	0.56%	40

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

44 Wealth Management's IDXX Position: Q4 2022 in Review

44 Wealth Management sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 2,682 shares — an estimated $874K sold.

44 Wealth Management first reported a position in IDXX in Q4 2020 and held it in 7 quarters. The position peaked at $1.94M in Q4 2021. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

44 Wealth Management reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
44 Wealth Management sold 2,682 Idexx Laboratories shares in Q4 2022, an estimated $874K.
44 Wealth Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 7 quarters.
44 Wealth Management's Idexx Laboratories position peaked at $1.94M in Q4 2021.
999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on 44 Wealth Management's 13F filing for Q4 2022, filed 20 Jan 2023.